Chronic Thrombocytopenia as the Initial Manifestation of STIM1-Related Disorders

Anjali Sura1, Joseph Jacher2, Erin Neil3

  • 1Divisions of Pediatric Rheumatology.

Pediatrics
|April 3, 2020
PubMed

Insights

Genetic testing revealed STIM1 variants causing Stormorken syndrome in a teen with chronic thrombocytopenia, constitutional symptoms, and myopathy. This case highlights overlapping phenotypes and the need for multidisciplinary care.

Area of Science:

  • Genetics
  • Pediatrics
  • Immunology

Background:

  • Pediatric thrombocytopenia presents a broad differential diagnosis.
  • Genetic testing is increasingly utilized to determine the etiology of thrombocytopenia.
  • Chronic thrombocytopenia can be associated with complex systemic symptoms.

Purpose of the Study:

  • To report a novel case of pediatric thrombocytopenia with overlapping Stormorken syndrome phenotypes.
  • To emphasize the importance of genetic testing in diagnosing complex pediatric hematologic disorders.
  • To highlight the diagnostic utility of muscle enzyme evaluation in patients with thrombocytopenia and myopathic symptoms.

Main Methods:

  • Case presentation of a 16-year-old male with chronic thrombocytopenia.
  • Comprehensive laboratory evaluation including inflammatory markers and muscle enzymes.
  • Diagnostic imaging (lymphadenopathy, asplenia) and muscle biopsy.
  • Ophthalmological assessment.
  • Genetic testing for STIM1 pathogenic variants.

Main Results:

  • The patient presented with chronic thrombocytopenia, constitutional symptoms, hand edema, inflammation, elevated muscle enzymes, lymphadenopathy, asplenia, and myopathy.
  • Genetic analysis identified a pathogenic STIM1 variant, consistent with autosomal dominant Stormorken syndrome.
  • The observed phenotype demonstrated an overlap between previously described gain-of-function and loss-of-function STIM1 variants.

Conclusions:

  • This case expands the phenotypic spectrum associated with STIM1 variants, blurring distinctions between related syndromes.
  • Multidisciplinary care and genetic testing are crucial for managing chronic, unexplained pediatric thrombocytopenia.
  • Elevated muscle enzymes should be considered in the workup of pediatric patients with thrombocytopenia and associated neuromuscular symptoms.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
201
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K